Paul F Urrutia

Array ( [id] => 10476114 [patent_doc_number] => 20150361131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-17 [patent_title] => 'HIGH TEMPERATURE DEAD END ANTIBODY FILTRATION' [patent_app_type] => utility [patent_app_number] => 14/655401 [patent_app_country] => US [patent_app_date] => 2013-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8360 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14655401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11127791 [patent_doc_number] => 20160324766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-10 [patent_title] => 'Prebiotic Oral Care Compositions Containing Amino Acids' [patent_app_type] => utility [patent_app_number] => 15/108105 [patent_app_country] => US [patent_app_date] => 2013-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10098 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15108105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13207191 [patent_doc_number] => 10117946 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-06 [patent_title] => Self-assembling ultrashort peptides modified with bioactive agents by click chemistry [patent_app_type] => utility [patent_app_number] => 14/655223 [patent_app_country] => US [patent_app_date] => 2013-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 20746 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 217 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14655223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9561894 [patent_doc_number] => 20140179604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-26 [patent_title] => 'GHRH AGONISTS FOR THE TREATMENT OF ISCHEMIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/138391 [patent_app_country] => US [patent_app_date] => 2013-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 53627 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14138391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9422380 [patent_doc_number] => 20140107031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-17 [patent_title] => 'TEMPLATE-FIXED PEPTIDOMIMETICS' [patent_app_type] => utility [patent_app_number] => 14/134566 [patent_app_country] => US [patent_app_date] => 2013-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 30130 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14134566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10975366 [patent_doc_number] => 20140378401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-25 [patent_title] => 'Ophthalmic Lipophilic and Hydrophilic Drug Delivery Vehicle Formulations' [patent_app_type] => utility [patent_app_number] => 14/132822 [patent_app_country] => US [patent_app_date] => 2013-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13090 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14132822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9635395 [patent_doc_number] => 20140213504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-31 [patent_title] => 'Cyclodextrin-Based Polymers for Therapeutic Delivery' [patent_app_type] => utility [patent_app_number] => 14/089208 [patent_app_country] => US [patent_app_date] => 2013-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 60547 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14089208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11090776 [patent_doc_number] => 20160287744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-06 [patent_title] => 'VASCULAR EMBOLIC SYSTEM' [patent_app_type] => utility [patent_app_number] => 14/442677 [patent_app_country] => US [patent_app_date] => 2013-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11405 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14442677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9463899 [patent_doc_number] => 20140128326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-08 [patent_title] => 'ALBUMIN VARIANTS' [patent_app_type] => utility [patent_app_number] => 14/075104 [patent_app_country] => US [patent_app_date] => 2013-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 40701 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14075104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12086820 [patent_doc_number] => 09840540 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-12 [patent_title] => 'Artificial bioparticle and method of manufacturing the same' [patent_app_type] => utility [patent_app_number] => 14/443503 [patent_app_country] => US [patent_app_date] => 2013-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 7252 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14443503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10405284 [patent_doc_number] => 20150290294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'METHODS FOR INHIBITING PLATELET AGGREGATION USING GLP-1 RECEPTOR AGONISTS' [patent_app_type] => utility [patent_app_number] => 14/440227 [patent_app_country] => US [patent_app_date] => 2013-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 7778 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14440227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10405328 [patent_doc_number] => 20150290338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'AFFINITY PEPTIDE-MODIFIED PARTICLES AND TARGETED DRUG DELIVERY METHODS' [patent_app_type] => utility [patent_app_number] => 14/437113 [patent_app_country] => US [patent_app_date] => 2013-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3769 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14437113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11276032 [patent_doc_number] => 09492503 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-15 [patent_title] => 'Surfactant protein D for the treatment of disorders associated with lung injury' [patent_app_type] => utility [patent_app_number] => 14/062682 [patent_app_country] => US [patent_app_date] => 2013-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8064 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14062682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10348891 [patent_doc_number] => 20150233896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-20 [patent_title] => 'Plasma H2S Levels as Biomarkers for Vascular Disease' [patent_app_type] => utility [patent_app_number] => 14/435231 [patent_app_country] => US [patent_app_date] => 2013-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5626 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14435231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14326561 [patent_doc_number] => 10294284 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-21 [patent_title] => Method for preparing C1q recombinant protein [patent_app_type] => utility [patent_app_number] => 14/434385 [patent_app_country] => US [patent_app_date] => 2013-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 10 [patent_no_of_words] => 7320 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14434385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9281320 [patent_doc_number] => 20140031288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-30 [patent_title] => 'NOVEL COMPOSITION FOR TUMOR GROWTH CONTROL' [patent_app_type] => utility [patent_app_number] => 14/044293 [patent_app_country] => US [patent_app_date] => 2013-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6603 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14044293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9491871 [patent_doc_number] => 20140142277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-22 [patent_title] => 'CYCLOSPORINE ANALOGUE MIXTURES AND THEIR USE AS IMMUNOMODULATING AGENTS' [patent_app_type] => utility [patent_app_number] => 14/042226 [patent_app_country] => US [patent_app_date] => 2013-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 25206 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14042226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9561279 [patent_doc_number] => 20140178993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-26 [patent_title] => 'Method and applications of peptide-mediated mitochondrial delivery system' [patent_app_type] => utility [patent_app_number] => 14/036597 [patent_app_country] => US [patent_app_date] => 2013-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 4009 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14036597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10656469 [patent_doc_number] => 20160002613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-07 [patent_title] => 'Cell Penetrating Peptide, Conjugate Comprising Same, and Composition Comprising Conjugate' [patent_app_type] => utility [patent_app_number] => 14/429641 [patent_app_country] => US [patent_app_date] => 2013-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 11985 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14429641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9777950 [patent_doc_number] => 08853154 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-07 [patent_title] => 'Fibronectin based scaffold domain proteins that bind to myostatin' [patent_app_type] => utility [patent_app_number] => 14/025307 [patent_app_country] => US [patent_app_date] => 2013-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 18 [patent_no_of_words] => 56986 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14025307 [rel_patent_id] =>[rel_patent_doc_number] =>)